i3.1 - Probiotic to improve IBS-related quality of life
Indicated by professional guidelines for the treatment of Irritable Bowel Syndrome (IBS)
i3.1 probiotic strains P. acidilactici KABP™ 021, L. plantarum KABP™ 022 and L. plantarum KABP™ 023 attacking S. sanguinis pathogen
Better IBS-related quality of life
Improves gut hypersensitivity
Helps regulate bowel movement
Helps reduce abdonimal pain (FDA responder criteria)
i3.1 is endorsed by several top-class gastrointestinal societies:
World Gastroenterology Organisation
Probiotics and prebiotics guideline, as a clinically-tested treatment for IBS
German Society of Gastroenterology
German S3-guideline for IBS, as a recommended microbiota-modulator treatment
i3.1 is the only probiotic that improves visceral hypersensitivity
AB-KOLICARE presents a well-described and unique mechanism of action:
naturally-sourced
Proprietary probiotic strains naturally found in the gut of healthy individuals. Only essential ingredients
tested as a co-treatment
Can be taken together with anti-spasmodics to increase therapeutic benefits, specially for abdominal pain
also for lactose intolerance
Improves general symptoms of lactose intolerance, including pain, flatulence and diarrea
clinically proven and safe
Three clinical trials with IBS and lactose intolerant patients. Safety approved by EFSA and FDA
Supplement that fits all diets: vegan certificate, plant-based origin.
Thank you for visiting us at IBS days!
